XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Net product sales $ 125,249 $ 110,403
Cost of goods sold 11,698 13,567
Gross profit 113,551 96,836
Operating expenses:    
Research and development 27,839 28,329
Selling, general, and administrative 91,827 88,029
Restructuring charges 0 6,045
Depreciation and amortization 1,837 2,154
Total operating expenses 121,503 124,557
Loss from operations (7,952) (27,721)
Other expense:    
Interest income 812 1,540
Interest expense (11,455) (12,436)
Other income (expense) 550 (4,966)
Loss before income tax (18,045) (43,583)
Income tax expense (3,641) (4,836)
Net loss attributable to common stockholders $ (21,686) $ (48,419)
Net loss attributable to common stockholders per common share - basic (in dollars per share) $ (0.07) $ (0.16)
Net loss attributable to common stockholders per common share — diluted (in dollars per share) $ (0.07) $ (0.16)
Weighted average common shares outstanding - basic (in shares) 307,689,207 302,903,009
Weighted average common shares outstanding - diluted (in shares) 307,689,207 302,903,009